CR Bard: Expansion Plans on Track, Product Pipeline Strong
Zacks Equity Research - Zacks Investment Research - Tue Jul 05, 8:29AM CDT
CR Bard had a robust performance in international markets, extensive expenditure on product innovation and a diversified product portfolio.
DSCI: 4.33 (+0.11), BCR: 238.55 (-0.45), CNMD: 49.29 (+0.61), COO: 182.18 (+0.35)
CR Bard (BCR) at 52-Week High on Strong Product Pipeline
Zacks Equity Research - Zacks Investment Research - Thu Jun 30, 7:27AM CDT
Shares of CR Bard (BCR) rallied to a new 52-week high of $232.77 on Jun 29.
HYH: 34.17 (-0.30), BSX: 23.97 (+0.07), BCR: 238.55 (-0.45), CNMD: 49.29 (+0.61)
DENTSPLY Sirona Set to Acquire MIS Implants for $375M
Zacks Equity Research - Zacks Investment Research - Tue Jun 28, 8:41AM CDT
DENTSPLY Sirona Inc. (XRAY) is set to acquire Israel-based MIS Implants Technologies for $375 million in cash.
HYH: 34.17 (-0.30), BCR: 238.55 (-0.45), CNMD: 49.29 (+0.61), XRAY: 63.55 (+0.16)
DENTSPLY Sirona (XRAY): Q1 Strong, Expansion on Track
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 8:19AM CDT
On Jun 17, we issued an updated research report on NY-based DENTSPLY Sirona Inc. (XRAY).
HYH: 34.17 (-0.30), BCR: 238.55 (-0.45), CNMD: 49.29 (+0.61), XRAY: 63.55 (+0.16)
Global Sports Medicine Market 2016-2020 - Key Vendors are Arthrex, CONMED, DePuy Synthes, Smith & Nephew & Stryker
GlobeNewswire - Wed Jun 15, 8:19AM CDT
Research and Markets has announced the addition of the "Global Sports Medicine Market 2016-2020" report to their offering.
SNN: 34.21 (-0.23), CNMD: 49.29 (+0.61)
Patterson Companies (PDCO) Q4 Earnings Top, Sales Strong
Zacks Equity Research - Zacks Investment Research - Thu May 26, 9:02AM CDT
Patterson Companies Inc. (PDCO) reported adjusted earnings of 77 cents per share from continuing operations that beat the Zacks Consensus Estimate by a penny.
HYH: 34.17 (-0.30), BCR: 238.55 (-0.45), CNMD: 49.29 (+0.61), PDCO: 49.47 (-0.36)
CONMED Corporation Announces Quarterly Cash Dividend
BusinessWire - Wed May 25, 3:01PM CDT
CONMED Corporation (NASDAQ:CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on July 6, 2016 to all shareholders of record as of June 15, 2016.
CNMD: 49.29 (+0.61)
Veeva Systems (VEEV) Q1 Earnings: What's in the Cards?
Zacks Equity Research - Zacks Investment Research - Mon May 23, 9:26AM CDT
Notably, Veeva (VEEV) posted an average positive surprise of 15.98% over the last four quarters.
VEEV: 37.58 (+0.21), AIRM: 38.09 (+0.27), CNMD: 49.29 (+0.61), LH: 135.78 (+0.48)
Can Patterson Companies (PDCO) Surprise in Q4 Earnings?
Zacks Equity Research - Zacks Investment Research - Mon May 23, 8:32AM CDT
Patterson Companies Inc. (PDCO) is set to announce fourth-quarter fiscal 2016 earnings on May 26.
AIRM: 38.09 (+0.27), CNMD: 49.29 (+0.61), PDCO: 49.47 (-0.36), LH: 135.78 (+0.48)
Becton, Dickinson's (BDX) MAX Vaginal Panel Gets CE Mark
Zacks Equity Research - Zacks Investment Research - Mon May 16, 6:42AM CDT
Becton, Dickinson and Company (BDX) recently announced the receipt of CE marking for its BD MAX Vaginal Panel.
BDX: 176.65 (+1.01), BCR: 238.55 (-0.45), MDT: 88.37 (+0.01), CNMD: 49.29 (+0.61)
DENTSPLY (XRAY) Tops Q1 Earnings & Sales, View Positive
Zacks Equity Research - Zacks Investment Research - Fri May 06, 8:19AM CDT
DENTSPLY SIRONA Inc. (XRAY) reported adjusted earnings of 69 cents per share in the first quarter of 2016 which beat the Zacks Consensus Estimate by 6 cents.
BCR: 238.55 (-0.45), VWR: 29.33 (+0.07), CNMD: 49.29 (+0.61), XRAY: 63.55 (+0.16)
Becton, Dickinson (BDX) Beats Q2 Earnings on Solid Sales
Zacks Equity Research - Zacks Investment Research - Thu May 05, 8:21AM CDT
Becton, Dickinson and Company (BDX) reported second-quarter fiscal 2016 earnings of $2.18 per share, which beat the Zacks Consensus Estimate by 17 cents.
BDX: 176.65 (+1.01), BCR: 238.55 (-0.45), ALGN: 83.15 (+0.22), CNMD: 49.29 (+0.61)
Conmed reports 1Q loss
Automated Insights - Wed Apr 27, 4:46PM CDT
UTICA, N.Y. (AP) _ Conmed Corp. (CNMD) on Wednesday reported a first-quarter loss of $2.3 million, after reporting a profit in the same period a year earlier.
CNMD: 49.29 (+0.61)
CONMED Corporation Announces First Quarter 2016 Financial Results
BusinessWire - Wed Apr 27, 3:01PM CDT
CONMED Corporation (Nasdaq:CNMD) today announced financial results for the first quarter ended March 31, 2016.
CNMD: 49.29 (+0.61)
CONMED Corporation to Present at the Deutsche Bank 41st Annual Health Care Conference
BusinessWire - Wed Apr 13, 3:05PM CDT
CONMED Corporation (NASDAQ:CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Luke A. Pomilio, Chief Financial Officer, will present at the Deutsche Bank 41st Annual Health Care Conference at 2:10 p.m. ET on Thursday, May 5, 2016 in Boston, MA.
CNMD: 49.29 (+0.61), DB: 13.14 (+0.17)
CONMED Corporation to Announce First Quarter 2016 Financial Results on April 27, 2016
BusinessWire - Wed Apr 06, 3:05PM CDT
CONMED Corporation (NASDAQ:CNMD) today announced that it will report financial results for the first quarter of fiscal year 2016 after the market close on Wednesday, April 27, 2016. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
CNMD: 49.29 (+0.61)
CONMED Corporation Announces Annual Meeting of Shareholders
BusinessWire - Mon Mar 07, 7:00AM CST
CONMED Corporation (NASDAQ: CNMD) today announced that its Annual Meeting of Shareholders will be held at the Company's corporate offices, 525 French Road, Utica, NY on Wednesday, May 25, 2016, at 2:30 p.m. ET. Shareholders of record at the close of business on April 7, 2016 shall be entitled to vote at the 2016 Annual Meeting.
CNMD: 49.29 (+0.61)
Global Orthopedic Surgical Power Tools Market Growth of 2.59% CAGR by 2020 - Analysis, Technologies & Forecast Report 2016-2020 - Key Vendors: CONMED, DePuy Synthes, Medtronic - Research and Markets
BusinessWire - Thu Mar 03, 2:45PM CST
Research and Markets (http://www.researchandmarkets.com/research/3b2wmv/global_orthopedic) has announced the addition of the "Global Orthopedic Surgical Power Tools Market 2016-2020" report to their offering.
MDT: 88.37 (+0.01), CNMD: 49.29 (+0.61)
CONMED Corporation to Present at the LEERINK Partners 5th Annual Global Healthcare Conference
BusinessWire - Mon Feb 01, 3:01PM CST
CONMED Corporation (NASDAQ: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Luke A. Pomilio, Chief Financial Officer, will present at the LEERINK Partners 5th Annual Global Healthcare Conference at 8:05 a.m. ET on Thursday, February 11, 2016 in New York, NY.
CNMD: 49.29 (+0.61)
CONMED Beats Q4 Earnings & Sales, FY16 View Impressive
Zacks Equity Research - Zacks Investment Research - Thu Jan 28, 10:15AM CST
CONMED Corp (CNMD) reported adjusted earnings of 52 cents per share, which beat the Zacks Consensus Estimate by a penny.
DSCI: 4.33 (+0.11), STAA: 6.12 (+0.13), CNMD: 49.29 (+0.61), OCLS: 4.16 (-0.16)